ONWARD_Logotype®_Red.png
ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System
March 18, 2024 02:30 ET | ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)    EINDHOVEN, the Netherlands, March 18, 2024 (GLOBE...
ONWARD_Logotype®_Red.png
ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
March 15, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA, March 15, 2024 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD_Logotype®_Red.png
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
March 15, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 15 mars 2024 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...
ONWARD_Logotype®_Red.png
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
March 15, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, March 15, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...
ONWARD_Logotype®_Red.png
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights
March 15, 2024 02:30 ET | ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company expects to commercialize its ARC-EX®...
ONWARD_Logotype®_Red.png
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
March 11, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, March 11, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
February 29, 2024 01:41 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
February 09, 2024 01:30 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 09, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
ONWARD_Logotype®_Red.png
ONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
February 07, 2024 15:55 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 07, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
January 25, 2024 17:11 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 25, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...